Literature DB >> 16023782

Dysferlin mutation in a Chinese pedigree with Miyoshi myopathy.

Sun Shunchang1, Qishi Fan, Wu Huacheng, France Leturcq, Song Yongjian, Zhang Bingfeng, Yu Wen, Nathalie Deburgrave.   

Abstract

OBJECTIVES: Mutations in the dysferlin gene cause two autosomal recessive forms of muscular dystrophy: Miyoshi myopathy and limb-girdle muscular dystrophy type 2B. The purpose of this study was to diagnose a Chinese pedigree with the autosomal recessive form of muscular dystrophy and conduct mutational screening.
METHODS: The pedigree was diagnosed accurately by using two-point linkage analysis and multi-Western blot analysis. Mutations were determined by reverse transcriptase polymerase chain reaction (RT-PCR) followed by DNA sequencing.
RESULTS: Two-point linkage analysis showed significant LOD scores with makers from chromosome 2p13. Multi-Western blot analysis confirmed dysferlin deficiency of muscle specimen from the propositus. Mutation analysis of the dysferlin gene revealed a novel mutation, 6429delG, on exon 53.
CONCLUSIONS: We identified an inbred Chinese pedigree with Miyoshi myopathy caused by the 6429delG mutation in the dysferlin gene. This mutation is predicted to result in premature termination of translation contributing to Miyoshi myopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023782     DOI: 10.1016/j.clineuro.2005.05.014

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  2 in total

1.  Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.

Authors:  Mafalda Cacciottolo; Gelsomina Numitone; Stefania Aurino; Imma Rosaria Caserta; Marina Fanin; Luisa Politano; Carlo Minetti; Enzo Ricci; Giulio Piluso; Corrado Angelini; Vincenzo Nigro
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

2.  Dysferlin Gene Mutation Spectrum in a Large Cohort of Chinese Patients with Dysferlinopathy.

Authors:  Su-Qin Jin; Meng Yu; Wei Zhang; He Lyu; Yun Yuan; Zhao-Xia Wang
Journal:  Chin Med J (Engl)       Date:  2016-10-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.